NCT04745143: Monotherapy of an NMDA Enhancer for Schizophrenia
- State
- Under way
- Phase
- Phase 2
- People
- 80 planned
- Started
- 1 Jan 2018
- Primary completion
- Sep 2027
- Arms
- NMDAE
- Results
- None posted
- 1 Jan 2018: Trial started
- 9 Feb 2021: Trial registered
A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set
Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.
Kind of treatment: Drug.
Registries searched: ClinicalTrials.gov, through 17 Nov 2026.